Autonomix Medical, Inc.
$0.4
▼
-1.99%
2026-04-21 05:16:01
autonomix.com
NCM: AMIX
Explore Autonomix Medical, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$4.63 M
Current Price
$0.4
52W High / Low
$2.82 / $0.34
Stock P/E
—
Book Value
$0.75
Dividend Yield
—
ROCE
-143.08%
ROE
-1.89%
Face Value
—
EPS
$-3.15
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
8
Beta
-2.46
Debt / Equity
—
Current Ratio
6.18
Quick Ratio
5.63
Forward P/E
-0.05
Price / Sales
—
Enterprise Value
$-5.6 M
EV / EBITDA
0.32
EV / Revenue
—
Rating
None
Target Price
$2
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | GE HealthCare Technologies Inc. | $71.58 | 15.76 | $32.85 B | 0.19% | 9.93% | 22.38% | $89.77 / $59.95 | $22.77 |
| 2. | Treace Medical Concepts, Inc. | $1.97 | — | $125.31 M | — | -33.86% | -58.94% | $7.78 / $1.17 | $1.37 |
| 3. | Quanterix Corporation | $3.3 | — | $164.29 M | — | -31.92% | -34.25% | $8.77 / $3.23 | $6.33 |
| 4. | Smith & Nephew plc | $32.71 | 22.84 | $14.01 B | 2.29% | 9.67% | 11.84% | $1,441.5 / $960.8 | $6.22 |
| 5. | CVRx, Inc. | $7.24 | — | $193.65 M | — | -56.04% | -96.59% | $11.3 / $4.3 | $1.5 |
| 6. | SS Innovations International, Inc. | $4.85 | — | $971.12 M | — | -17.08% | -46.94% | $22.42 / $3.02 | $0.2 |
| 7. | Bio-Rad Laboratories, Inc. | $302.22 | 10.88 | $8.04 B | — | 2.17% | 10.84% | $343.12 / $211.43 | $276.16 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M | — |
| Operating Profit | -3.34 M | -7.53 M | -3.42 M | -3.25 M | -2.75 M | — |
| Net Profit | -3.26 M | -7.45 M | -3.34 M | -3.19 M | -2.71 M | — |
| EPS in Rs | -0.29 | -0.65 | -0.29 | -0.28 | -0.24 | -2.27 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Sales | 0 M | 0 M | 0 M |
| Operating Profit | -11.59 M | -7.47 M | -1.99 M |
| Net Profit | -11.41 M | -15.43 M | -1.99 M |
| EPS in Rs | -1 | -1.35 | -0.17 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Total Assets | 9.81 M | 9.41 M | 0.86 M |
| Total Liabilities | 1.71 M | 1.78 M | 0.22 M |
| Equity | 8.1 M | 7.63 M | 0.64 M |
| Current Assets | 9.61 M | 9.39 M | 0.86 M |
| Current Liabilities | 1.71 M | 0.78 M | 0.22 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Operating CF | -8.26 M | -6.65 M | -1.85 M |
| Investing CF | -0.01 M | -0.02 M | 0 M |
| Financing CF | 8.8 M | 14.41 M | 0.68 M |
| Free CF | -8.27 M | -6.67 M | -1.85 M |
| Capex | -0.01 M | -0.02 M | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue Growth % | — | — | — |
| Earnings Growth % | 26.03% | -675.18% | — |
| Profit Margin % | — | — | — |
| Operating Margin % | — | — | — |
| Gross Margin % | — | — | — |
| EBITDA Margin % | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2024-10-25 | 1:0.05 |